Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Kyowa Kirin
Sort By
Newest First
1 / 1
1 / 1
Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma, Inc.
PR-M11-18-NI-026
Nov 08, 2018
FDA Approval
Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin
PR-M08-18-NI-109
Aug 29, 2018
